Can a simple blood test predict cancer survival?
NCT ID NCT06202131
Summary
This study aims to see if analyzing tiny bits of tumor DNA found in blood and stool (called ctDNA) can help doctors better manage treatment for people with cancers of the digestive system, like pancreatic, colon, and bile duct cancer. It will observe 100 patients to see if these test results are linked to how long patients live. This is an observational study that collects samples and data; it does not test any new drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Policlinico Agostino Gemelli
RECRUITINGRome, Lazio, 00168, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.